A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease.

Source:http://linkedlifedata.com/resource/pubmed/id/20231298

Download in:

View as

General Info

PMID
20231298